0 0 -0.00094996833438874 -0.00094996833438874 -0.00109510238547594 -0.000936774329744462 -0.00121384842727459 -0.00121384842727459
Sign Up Today X
Thanks for submitting the form.
Stockreport

AbbVie Signs US Deal to Cut Drug Prices, Secure Tariff Exemptions [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc. (REGN)  More Company Research Source: Yahoo! Finance
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
its pricing and investment strategy, committing to reduce prices on certain medicines while pledging $100 billion of domestic investment in exchange for exemptions from specific tariffs. The arrangement comes as the Trump administration continues to apply tariff pressure on major drugmakers to expand their US footprint and ease drug costs, using trade policy as leverage to push structural changes across the sector. Warning! GuruFocus has detected 9 Warning Signs with ABBV. Is ABBV fairly valued? Test your thesis with our free DCF calculator. AbbVie said the agreement addresses four demands outlined by the administration, including increased US investment, lower Medicaid pricing, direct-to-patient drug sales, and pricing parity between the US and overseas markets. Trump sent letters to 17 drugmakers in July urging them to adopt these measures, and publicly available information indicates that every company except Regeneron Pharmaceuticals Inc. has since reached a similar deal. As [Read more]
IMPACT SNAPSHOT EVENT TIME: REGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
REGN alerts
from News Quantified
REGN
NEWS
REGN
Earnings
REGN
Analyst Actions
REGN
SEC Filings
Stockreport

AbbVie Signs US Deal to Cut Drug Prices, Secure Tariff Exemptions [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc.  (REGN) 
More Company Research Source: Yahoo! Finance
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
its pricing and investment strategy, committing to reduce prices on certain medicines while pledging $100 billion of domestic investment in exchange for exemptions from specific tariffs. The arrangement comes as the Trump administration continues to apply tariff pressure on major drugmakers to expand their US footprint and ease drug costs, using trade policy as leverage to push structural changes across the sector. Warning! GuruFocus has detected 9 Warning Signs with ABBV. Is ABBV fairly valued? Test your thesis with our free DCF calculator. AbbVie said the agreement addresses four demands outlined by the administration, including increased US investment, lower Medicaid pricing, direct-to-patient drug sales, and pricing parity between the US and overseas markets. Trump sent letters to 17 drugmakers in July urging them to adopt these measures, and publicly available information indicates that every company except Regeneron Pharmaceuticals Inc. has since reached a similar deal. As [Read more]
IMPACT SNAPSHOT
EVENT TIME:
REGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS